Impact Factor
3.22
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.52
301 total citations
h5-index
25
h5 depth signal
Cited share
72.7%
96 of 132
Total citations
301
Citation footprint
Metric signal
2.28
External metric anchor
Self-citation
2.7%
8 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
427
China
67
Brazil
67
Italy
65
Iran
50
Citing Fields of Research
HIV
415
Viral Identification & Phylogenetics
228
Virology
175
Tropical Diseases
103
Neuromuscular Disorders
102
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,536
Articles tracked across the journal lifetime
Indexed publication set
132
96 cited publications
Last 12 months
62
5.2 publications/month
Open access share
48.4%
30 OA publications in the last year
Leading citing country
United States
427 citing publications
Leading citing field
HIV
415 citing publications
Latest tracked publication
13 October 2026
10 recent records available
Coverage & Indexing History
v1n1,Mar. 1995-
v1n1,Mar. 1995-
Active Coverage
Research Focus & Classification
Indexed Subjects
HIV
Viral Identification & Phylogenetics
Neurodegenerative Disorders
Virology
Tropical Diseases
Broad Categories
Neurology
Virology
HIV
Viral Identification & Phylogenetics
Neuromuscular Disorders
MeSH Descriptors
Nervous System Diseases
Virus Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s13365-026-01348-0
Open DOI
Evidence that intrinsic brain connectivity moderates the association between gait and neurocognitive function in people living with HIV
Globally, a substantial proportion of the approximately 40 million people living with HIV (PLWH) experience some degree of HIV-associated brain injury (HABI), which is often linked to accentuated or accelerated aging in this clinical pop...
02
DOI 10.1007/s13365-026-01345-3
Open DOI
Varicella zoster virus meningitis with a dermatomal rash in immunocompetent hosts: a systematic review and novel case report
Varicella zoster virus (VZV) reactivation with central nervous system (CNS) involvement is an uncommon but important cause of lymphocytic meningitis in both immunocompromised and immunocompetent individuals. While cranial presentations, ...
03
DOI 10.1007/s13365-026-01336-4
Open DOI
HAND in Africa: prevalence, diagnostic challenges and the search for objective markers
HIV Associated Neurocognitive Disorder (HAND) affects 20–50% of people with HIV (PWH) on suppressive antiretroviral therapy, with about 72% of the 16 million global cases residing in sub-Saharan Africa. Despite this disproportionate burd...
04
DOI 10.1007/s13365-026-01314-w
Open DOI
Expanding the spectrum of oropouche virus neurological disease: emerging evidence from the 2025 Panama outbreak
05
DOI 10.1007/s13365-026-01343-5
Open DOI
HIV cure: from early therapies to cutting-edge strategies
HIV has challenged humanity for decades, quietly establishing latent reservoirs that evade even the most potent antiretroviral therapies (ART). While ART transformed HIV from a fatal disease into a manageable condition, the virus’s hidde...
06
DOI 10.1007/s13365-026-01333-7
Open DOI
CRISPR-mediated excision of HTLV-1 reduces proviral loads in PBMCs from HAM/TSP patients
CRISPR technology is emerging as a promising therapeutic approach for eliminating chronic viral infections, such as herpesviruses and HIV. Here, for the first time, we demonstrate in vitro that CRISPR can be used to excise the HTLV-1 gen...
07
DOI 10.1007/s13365-026-01341-7
Open DOI
From viral epigenetic reprogramming to neuroinflammation: Mechanisms driving neurodegeneration
08
DOI 10.1007/s13365-026-01340-8
Open DOI
Systematic review and multilevel meta-analysis of preclinical survival outcomes of Zika virus–based oncolytic therapy in glioblastoma
Glioblastoma remains a highly lethal primary brain tumor with limited therapeutic options. Zika virus (ZIKV) has emerged as a candidate oncolytic platform because of its tropism for glioblastoma stem-like cells and its immunomodulatory p...
09
DOI 10.1007/s13365-026-01338-2
Open DOI
Impact of cannabis use on white matter hyperintensities in adults with and without chronic HIV disease
White matter hyperintensities (WMH) are prevalent among people living with HIV (PLWH), even with sustained viral suppression on antiretroviral therapy. This study investigated whether cannabis use contributes to additional WMH load among...
10
Bibliographical & Catalog Notes
Supplements accompany some vols.
Also issued online.
Vol. 1, no. 1 (JAN 1995)19960129 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper